Submit Feedback
Recent searches
    Trending searches
    +

    Cigna Corporation Competitors & Alternatives

    Cigna Corporation competitors and alternatives

    Jump
    Company
    Ticker
    CI
    Headquarter
    Bloomfield ,CT
    US
    CEO
    Mr. David Michael Cordani
    Industry
    Medical - Healthcare Plans
    Stock Price
    Stock Price
    Market Cap
    $78.08B
    Employees
    Years
    • 2021
    • 2022
    • 2023
    Employees
    • 73.70K
    • 71.30K
    • 72.50K
    Y/Y
    0%
    3.26%
    1.68%

    Income Statement

    Revenue
    Years
    • 2021
    • 2022
    • 2023
    Revenue
    • $174.27B
    • $180.64B
    • $195.19B
    Y/Y
    8.53%
    3.66%
    8.05%
    Revenue by Products / Services
    Revenue by Geography
    Research and Development
    Years
    • 2021
    • 2022
    • 2023
    Research and Development
    • -
    • -
    • -
    Y/Y
    0%
    0%
    0%
    Operating Income
    Years
    • 2021
    • 2022
    • 2023
    Operating Income
    • $8.35B
    • $9.50B
    • $8.54B
    Y/Y
    4.15%
    13.78%
    10.18%
    Tax Rate (%)
    Years
    • 2021
    • 2022
    • 2023
    Tax Rate (%)
    • 20.00%
    • 19.00%
    • 3.00%
    Y/Y
    7.9%
    4.56%
    86.69%
    Net Income
    Years
    • 2021
    • 2022
    • 2023
    Net Income
    • $5.37B
    • $6.70B
    • $5.16B
    Y/Y
    36.51%
    24.84%
    22.97%

    Assets & Liabilities | Cash Flow

    Total Assets
    Years
    • 2021
    • 2022
    • 2023
    Total Assets
    • $154.89B
    • $143.93B
    • $152.76B
    Y/Y
    0.36%
    7.07%
    6.13%
    Total Liabilities
    Years
    • 2021
    • 2022
    • 2023
    Total Liabilities
    • $107.71B
    • $98.98B
    • $106.41B
    Y/Y
    2.51%
    8.1%
    7.51%
    Capital Expenditures (Capex)
    Years
    • 2021
    • 2022
    • 2023
    Capital Expenditures (Capex)
    • -$1.15B
    • -$1.30B
    • -$1.57B
    Y/Y
    5.48%
    12.22%
    21.47%

    Profitability

    Operating Income Margin (%)
    Years
    • 2021
    • 2022
    • 2023
    Operating Income Margin (%)
    • 4.79%
    • 5.26%
    • 4.37%
    Y/Y
    11.79%
    9.81%
    16.92%
    Net Income Margin (%)
    Years
    • 2021
    • 2022
    • 2023
    Net Income Margin (%)
    • 3.08%
    • 3.71%
    • 2.65%
    Y/Y
    41.56%
    20.45%
    28.57%
    EBITDA
    Years
    • 2021
    • 2022
    • 2023
    EBITDA
    • $10.91B
    • $12.55B
    • $9.99B
    Y/Y
    27.77%
    15%
    20.42%
    Free Cash Flow (FCF)
    Years
    • 2021
    • 2022
    • 2023
    Free Cash Flow (FCF)
    • $6.04B
    • $7.36B
    • $10.24B
    Y/Y
    34.78%
    21.93%
    39.11%

    Ratios

    Return on Equity (ROE)
    Years
    • 2021
    • 2022
    • 2023
    Return on Equity (ROE)
    • 11.40%
    • 14.94%
    • 11.17%
    Y/Y
    32.18%
    31.05%
    25.23%
    Return on Assets (ROA)
    Years
    • 2021
    • 2022
    • 2023
    Return on Assets (ROA)
    • 3.47%
    • 4.66%
    • 3.38%
    Y/Y
    36.21%
    34.29%
    27.47%
    Debt to Equity
    Years
    • 2021
    • 2022
    • 2023
    Debt to Equity
    • 71.47%
    • 69.29%
    • 66.77%
    Y/Y
    9.25%
    3.05%
    3.64%

    Valuation

    Enterprise Value
    Years
    • 2021
    • 2022
    • 2023
    Enterprise value
    • $106.20B
    • $127.73B
    • $111.11B
    Y/Y
    7.57%
    20.28%
    13.01%
    Enterprise value to Revenue
    Years
    • 2021
    • 2022
    • 2023
    Enterprise value to Revenue
    • 0.61
    • 0.71
    • 0.57
    Y/Y
    0.88%
    16.03%
    19.49%
    Enterprise value to EBITDA
    Years
    • 2021
    • 2022
    • 2023
    Enterprise value to EBITDA
    • 9.73
    • 10.18
    • 11.13
    Y/Y
    48.93%
    4.59%
    9.31%

    Related company

    Submit feedback to Bullfincher